Evidence map›Paper›PMID 38924438›Full record

ReviewArteriosclerosis, thrombosis, and vascular biology2024

RAGE/DIAPH1 Axis and Cardiometabolic Disease: From Nascent Discoveries to Therapeutic Potential.

Ravichandran Ramasamy, Alexander Shekhtman, Ann Marie Schmidt

Abstract readReview
In one paragraph

Review in Arteriosclerosis, thrombosis, and vascular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ravichandran RamasamyDiabetes Research Program, Department of Medicine, New York University Grossman School of Medicine, NYU Langone Medical Center (R.R., A.M.S.).
Alexander ShekhtmanDepartment of Chemistry, State University of New York at Albany (A.S.).ORCID 0000-0003-2649-2675
Ann Marie SchmidtDiabetes Research Program, Department of Medicine, New York University Grossman School of Medicine, NYU Langone Medical Center (R.R., A.M.S.).ORCID 0000-0001-8902-070X

Funding

Resolving Macrophage Inflammation in Atherosclerotic Plaques and Other Sites in Insulin ResistanceP01HL131481 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Edward A Fisher · 2017 to 2026
$27.3M
Project 3: RAGE/DIAPH1 interactions and cellular stressP01HL146367 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SCHMIDT, ANN MARIE · 2019 to 2023
$12.5M
Targeting RAGE/DIAPH1: Novel Therapeutic Strategy for Diabetic ComplicationsR01DK122456 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI RAMASAMY, RAVICHANDRAN, SCHMIDT, ANN MARIE · 2020 to 2024
$3.1M
NHLBI NIH HHS P01 HL131481NHLBI NIH HHS P01 HL146367NIDDK NIH HHS R01 DK122456
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cardiovascular DiseasesReceptor for Advanced Glycation End ProductsSignal TransductionAdaptor Proteins, Signal TransducingAnimalsGlycation End Products, AdvancedHumansMetabolic DiseasesAdaptor Proteins, Signal TransducingAGER protein, humanGlycation End Products, AdvancedReceptor for Advanced Glycation End Productscardiovascular diseaseshyperlipidemiasmetabolic diseases

Identifiers

PMID38924438
PMCPMC11210684

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.